載入...
EGFR Exon-Level Biomarkers of the Response to Bevacizumab/Erlotinib in Non-Small Cell Lung Cancer
Activating epidermal growth factor receptor (EGFR) mutations are recognized biomarkers for patients with metastatic non-small cell lung cancer (NSCLC) treated with EGFR tyrosine kinase inhibitors (TKIs). EGFR TKIs can also have activity against NSCLC without EGFR mutations, requiring the identificat...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3769372/ https://ncbi.nlm.nih.gov/pubmed/24039832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0072966 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|